IDXX – IDEXX Laboratories, Inc. – Fundamental analysis, financial statements, key ratios, and fair value analysis

IDEXX Laboratories, Inc.

Healthcare
Diagnostics & Research
187.43
9.41
5.29%
254.46
165.08
Stock Current Price
Change
Change %
52 Week High
52 Week Low

Financial Ratios

Earnings per Share (EPS)3.72
EPS Estimate Currrent Qtr0.9
Book Value Per Share-0.02
Market Cap 16 Billion
PE Ratio 47.4
Dividend YieldNA

Stock Yield

Stock Return 7 Days5.51%
Stock Return 15 Days1.14%
Stock Return 30 Days -9.92%
Stock Return 3 Months-23.31%
Stock Return One Year17.79%
Stock Return 3 Years17.88%

Stock Technical Analysis

Relative Strengh Index (14)30.4
Average True Range (14)7.22
Momentum (14)-21.71
Simple Moving Average (14) -21.71
Time Series Forecast (14)180.67
Time Series Forecast (30) 199.58

Stock News

Financial Statements

index2014201520162017
Revenue1 Billion2 Billion2 Billion2 Billion
Cost of Revenue670 Million712 Million800 Million872 Million
Gross Profit816 Million890 Million975 Million1 Billion
Gross Margin (%)54.93%55.58%54.94%55.73%
Selling General and Administrative Expense458 Million482 Million524 Million575 Million
Other operating expenses97 Million105 Million97 Million104 Million
Earning Before Interest and Taxes EBIT262 Million302 Million354 Million418 Million
EBIT/Operating Margin (%)17.63%18.87%19.93%21.24%
Interest Expense15 Million29 Million32 Million37 Million
Other non-operating expenses/income0000
Earnings before Tax247 Million273 Million322 Million381 Million
Income Tax Expense65 Million81 Million100 Million118 Million
Net Income182 Million192 Million222 Million263 Million
Net Margin (%)12.24%11.99%12.51%13.36%
Earnings per share from operating income0.8044520.7677850.653180.540504
Earnings per Diluted Share1.792.052.442.94
Dividends per Basic Common Share0000
Weighted average number of shares outstanding102 Million94 Million91 Million90 Million
index2017 Q42018 Q12018 Q22018 Q3
Revenue506 Million538 Million581 Million545 Million
Cost of Revenue234 Million235 Million248 Million240 Million
Gross Profit272 Million303 Million332 Million306 Million
Gross Margin (%)53.84%56.37%57.24%56.04%
Selling General and Administrative Expense146 Million161 Million157 Million159 Million
Other operating expenses27 Million28 Million29 Million29 Million
Earning Before Interest and Taxes EBIT99 Million114 Million146 Million118 Million
EBIT/Operating Margin (%)19.63%21.13%25.10%21.55%
Interest Expense10 Million9 Million8 Million8 Million
Other non-operating expenses/income0000
Earnings before Tax90 Million104 Million137 Million109 Million
Income Tax Expense51 Million15 Million29 Million16 Million
Net Income38 Million89 Million109 Million93 Million
Net Margin (%)7.56%16.64%18.72%17.10%
Earnings per share from operating income6.040541.257371.090411.20033
Earnings per Diluted Share0.431.011.231.05
Dividends per Basic Common Share0000
Weighted average number of shares outstanding89 Million89 Million88 Million89 Million
index2014201520162017
Cash and Equivalents323 Million129 Million155 Million188 Million
Trade and Non Trade Receivables152 Million188 Million204 Million235 Million
Inventory160 Million189 Million158 Million164 Million
Other current assets769 Million573 Million638 Million761 Million
Current Assets759 Million822 Million846 Million972 Million
Total Non-Current Assets625 Million653 Million685 Million741 Million
Total Assets1 Billion1 Billion2 Billion2 Billion
Trade and Non Trade Payables45 Million53 Million60 Million67 Million
Other current liabilities776 Million804 Million875 Million938 Million
Current Liabilities821 Million857 Million935 Million1 Billion
Liabilities Non Current446 Million702 Million704 Million763 Million
Accumulated Retained Earnings Deficit2 Billion318 Million540 Million804 Million
Shareholder’s equity other-2 Billion-402 Million-649 Million-858 Million
Shareholders Equity118 Million-84 Million-108 Million-54 Million
Noncontrolling interests2 Billion2 Billion2 Billion2 Billion
Total Assets1 Billion1 Billion2 Billion2 Billion
index2017 Q42018 Q12018 Q22018 Q3
Cash and Equivalents188 Million159 Million175 Million147 Million
Trade and Non Trade Receivables235 Million260 Million265 Million265 Million
Inventory164 Million179 Million176 Million180 Million
Other current assets761 Million422 Million473 Million407 Million
Current Assets972 Million702 Million740 Million704 Million
Total Non-Current Assets741 Million768 Million781 Million840 Million
Total Assets2 Billion1 Billion2 Billion2 Billion
Trade and Non Trade Payables67 Million70 Million68 Million65 Million
Other current liabilities938 Million658 Million706 Million694 Million
Current Liabilities1 Billion729 Million774 Million760 Million
Liabilities Non Current763 Million790 Million787 Million786 Million
Accumulated Retained Earnings Deficit804 Million880 Million989 Million1 Billion
Shareholder’s equity other-858 Million-930 Million-1 Billion-1 Billion
Shareholders Equity-54 Million-49 Million-41 Million-2 Million
Noncontrolling interests2 Billion1 Billion2 Billion2 Billion
Total Assets2 Billion1 Billion2 Billion2 Billion
index2014201520162017
Net Cash Flow from Operations236 Million222 Million339 Million373 Million
Capital Expenditure-61 Million-83 Million-65 Million-77 Million
Net Cash Flow from Investing-80 Million-308 Million-91 Million-139 Million
Net Cash Flow from Financing-103 Million-101 Million-222 Million-208 Million
Cash and Equivalents323 Million129 Million155 Million188 Million
index2017 Q42018 Q12018 Q22018 Q3
Net Cash Flow from Operations121 Million35 Million119 Million111 Million
Capital Expenditure-22 Million-24 Million-28 Million-32 Million
Net Cash Flow from Investing-24 Million260 Million-28 Million-54 Million
Net Cash Flow from Financing-78 Million-325 Million-71 Million-84 Million
Cash and Equivalents188 Million159 Million175 Million147 Million

Stock Price History

table